The MYST3/CREBBP fusion protein results in a unique AML characterized by monocytic or myelomonocytic morphology, extramedullary involvement, disseminated intravascular coagulation (DIC), and hemophagocytosis. Here, CREBBP is linked to acute myeloid leukemia.